RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $290M
- YoY, 2025
- +12,267.5%
- 5-year CAGR
- +121.6%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $290M | +12,267.5% |
| 2024 | $2.3M | −0.6% |
| 2023 | $2.4M | +8.6% |
| 2022 | $2.2M | −11.2% |
| 2021 | $2.4M | −55.0% |
| 2020 | $5.4M | — |
| 2019 | $0 | — |
| 2018 | $0 | — |